News

The study established the safety of HDL therapy as a potential treatment for atherosclerosis, a disease of blood vessels caused by the build-up of cholesterol-filled plaques in the

MVA vaccines are a weakened form of smallpox vaccine. MVA3000 is being developed for use in people for whom the traditional smallpox vaccine is not recommended, such as

Patients with a diagnosis of stage three or four malignant melanoma who have not been previously treated with chemotherapy for their metastatic disease are being recruited. Melanoma is

The company expects to file an investigational new drug application (IND) in late 2005 or early 2006, followed by a biologic license application in the second half of

The objectives of the study are to determine the maximum tolerated dose, and to evaluate the safety and pharmacokinetics of the drug. Up to 40 patients will be

The FDA intervened in 2003 to stop trials of Varisolve amid fears that the treatment could increase the risk of embolism in patients. In March 2005, Provensis submitted

The report gives twelve observations that raise concerns about the quality control and reporting procedures within Able. Most pertinently the report claims “the quality unit and senior management

As part of the $300 million takeover, shareholders will receive $4.40 in cash for each share of common stock, $517.65 in cash for each share of Series A

“This collaboration represents yet another important disease biomarker discovery program for Caprion,” noted Dr Daniel Chelsky, chief scientific officer of Caprion Pharmaceuticals. “This study reflects how Caprion’s biomarker